Evaluation Value of Blood Biomarker Tests for Efficacy of EGFR-TKI in Advanced NSCLC Treatment
ObjectiveTo analyze the levels of serum CTCs and ctDNA in NSCLC patients receiving first-line EGFR-TKI treatment, and to explore the clinical value of CTCs and ctDNA detection in assessing the efficacy of treatment for advanced lung cancer. MethodsA total of 109 NSCLC patients receiving first-line E...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Chinês |
| 出版事項: |
Magazine House of Cancer Research on Prevention and Treatment
2025-05-01
|
| シリーズ: | Zhongliu Fangzhi Yanjiu |
| 主題: | |
| オンライン･アクセス: | http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.1017 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|